Literature DB >> 26031784

Cervical cancer: squamocolumnar junction ablation--tying up loose ends?

Michael Herfs1, Christopher P Crum2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26031784     DOI： 10.1038/nrclinonc.2015.104

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Cancer of the uterine cervix; a preventable disease.

Authors:  P A YOUNGE
Journal:  Obstet Gynecol       Date:  1957-11       Impact factor: 7.661

2.  Risk of cervical cancer among an electrocoagulated population.

Authors:  T Kauraniemi; U Räsänen-Virtanen; M Hakama
Journal:  Am J Obstet Gynecol       Date:  1978-07-01       Impact factor: 8.661

3.  Carcinogenic HPV infection in the cervical squamo-columnar junction.

Authors:  Jelena Mirkovic; Brooke E Howitt; Patrick Roncarati; Stephanie Demoulin; Meggy Suarez-Carmona; Pascale Hubert; Frank D McKeon; Wa Xian; Anita Li; Philippe Delvenne; Christopher P Crum; Michael Herfs
Journal:  J Pathol       Date:  2015-04-27       Impact factor: 7.996

4.  Residual embryonic cells as precursors of a Barrett's-like metaplasia.

Authors:  Xia Wang; Hong Ouyang; Yusuke Yamamoto; Pooja Ashok Kumar; Tay Seok Wei; Rania Dagher; Matthew Vincent; Xin Lu; Andrew M Bellizzi; Khek Yu Ho; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-06-24       Impact factor: 41.582

5.  The importance of cauterization to maintain a healthy cervix. Long-term study from a private gynecologic practice.

Authors:  F W Peyton; R R Peyton; V L Anderson; P Pavnica
Journal:  Am J Obstet Gynecol       Date:  1978-06-15       Impact factor: 8.661

6.  A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer.

Authors:  Michael Herfs; Yusuke Yamamoto; Anna Laury; Xia Wang; Marisa R Nucci; Margaret E McLaughlin-Drubin; Karl Münger; Sarah Feldman; Frank D McKeon; Wa Xian; Christopher P Crum
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

7.  Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.

Authors:  Mariëlle Kocken; Theo J M Helmerhorst; Johannes Berkhof; Jacqueline A Louwers; Mariëlle A E Nobbenhuis; Aagje G Bais; Cornelis J A Hogewoning; Afra Zaal; René H M Verheijen; Peter J F Snijders; Chris J L M Meijer
Journal:  Lancet Oncol       Date:  2011-05       Impact factor: 41.316

Review 8.  Global burden of human papillomavirus and related diseases.

Authors:  David Forman; Catherine de Martel; Charles J Lacey; Isabelle Soerjomataram; Joannie Lortet-Tieulent; Laia Bruni; Jerome Vignat; Jacques Ferlay; Freddie Bray; Martyn Plummer; Silvia Franceschi
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

9.  Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa.

Authors:  Sylvia Taylor; Chunhui Wang; Thomas C Wright; Lynette Denny; Wei-Yann Tsai; Louise Kuhn
Journal:  BMC Med       Date:  2010-06-29       Impact factor: 8.775

10.  Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction.

Authors:  Michael Herfs; Joan Somja; Brooke E Howitt; Meggy Suarez-Carmona; Gaelle Kustermans; Pascale Hubert; Jean Doyen; Frederic Goffin; Frederic Kridelka; Christopher P Crum; Philippe Delvenne
Journal:  Int J Cancer       Date:  2014-07-03       Impact factor: 7.316
  10 in total
  7 in total

Review 1.  Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.

Authors:  Riccardo Di Fiore; Sherif Suleiman; Rosa Drago-Ferrante; Yashwanth Subbannayya; Francesca Pentimalli; Antonio Giordano; Jean Calleja-Agius
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

2.  Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia.

Authors:  Sanjida Mahjabeen; Manolya K Hatipoglu; Vishal Chandra; Doris M Benbrook; Lucila Garcia-Contreras
Journal:  J Pharm Sci       Date:  2017-10-06       Impact factor: 3.534

3.  Influence of the estrus cycle of the mouse on the disposition of SHetA2 after vaginal administration.

Authors:  Sanjida Mahjabeen; Manolya Kukut Hatipoglu; Doris M Benbrook; Stanley D Kosanke; David Garcia-Contreras; Lucila Garcia-Contreras
Journal:  Eur J Pharm Biopharm       Date:  2018-07-04       Impact factor: 5.571

4.  Pharmacokinetics and Pharmacodynamics of Escalating Doses of SHetA2 After Vaginal Administration to Mice.

Authors:  Sanjida Mahjabeen; Manolya Kukut Hatipoglu; Doris M Benbrook; Lucila Garcia-Contreras
Journal:  J Pharm Sci       Date:  2018-09-06       Impact factor: 3.534

Review 5.  Deciphering the Multifactorial Susceptibility of Mucosal Junction Cells to HPV Infection and Related Carcinogenesis.

Authors:  Michael Herfs; Thing R Soong; Philippe Delvenne; Christopher P Crum
Journal:  Viruses       Date:  2017-04-20       Impact factor: 5.048

6.  Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian Women.

Authors:  Brooke E Howitt; Michael Herfs; Tamiwe Tomoka; Steve Kamiza; Tarik Gheit; Massimo Tommasino; Philippe Delvenne; Christopher P Crum; Danny Milner
Journal:  J Glob Oncol       Date:  2016-08-10

Review 7.  Cancer stem cells (CSCs), cervical CSCs and targeted therapies.

Authors:  Ruixia Huang; Einar K Rofstad
Journal:  Oncotarget       Date:  2017-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.